AN
Cellbxhealth PLC
ANPCF · OTC
$0.02 +0.00% (+$0.00)
Market Cap £16.7M
P/E Ratio -
Div. Yield -
ROE 343.50%
Piotroski F-Score Weak
2/9Valuation
25 /100
Expensive P/B 4.10x
P/S 9.71x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 22.96%
Rev. growth 41.37%
FCF growth N/A
Profitability
0 /100
Weak Net margin 1,125.05%
Op. margin 1,127.69%
FCF margin 761.66%
Quality
3 /100
Poor ROE 343.50%
ROA 250.13%
Asset turnover 0.22x
Debt
68 /100
Low Current ratio 2.54x
Int. coverage -85.28x
Debt/Equity 0.32x
Stability
31 /100
Unstable Rev. volatility 55.59%
EPS volatility 35.11%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ANPCF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Michael Collins
Employees
119
Headquarters
Guildford
Evenimente viitoare
29 APR.
Earnings
Upcoming earnings report